Evidence map›Paper›PMID 28422070›Full record

ArticleInternational journal of molecular sciences2017

One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet.

Anke Schmidt, Thomas von Woedtke, Jan Stenzel, Tobias Lindner, Stefan Polei, Brigitte Vollmar, Sander Bekeschus

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06543316 (Accelerated Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06543316 narecruitingnot on this mapstarted 2025, after this paper: background citation

Accelerated Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment

TypeinterventionalSponsorChristopher C. Thompson, MD, MScRan2025 to 2028Enrolled100ConditionsRoux-en-y Anastomosis Site, Marginal Ulcer, Marginal Ulcer (Peptic) or Erosion, UlcerArmsLow Thermal Plasma (LTP) Treatment, Standard of Care Ulcer Treatment (typically PPI Administration)
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anke SchmidtLeibniz-Institute for Plasma Science and Technology (INP Greifswald), Departments of Plasma Life Science and ZIK Plasmatis, Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany. anke.schmidt@inp-greifswald.de.
Thomas von WoedtkeLeibniz-Institute for Plasma Science and Technology (INP Greifswald), Departments of Plasma Life Science and ZIK Plasmatis, Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany. woedtke@inp-greifswald.de.
Jan StenzelCore Facility Multimodal Small Animal Imaging, 18057 Rostock, Germany. jan.stenzel@med.uni-rostock.de.
Tobias LindnerCore Facility Multimodal Small Animal Imaging, 18057 Rostock, Germany. tobias.lindner@med.uni-rostock.de.
Stefan PoleiCore Facility Multimodal Small Animal Imaging, 18057 Rostock, Germany. stefan.polei@med.uni-rostock.de.
Brigitte VollmarInstitute for Experimental Surgery, Rostock University Medical Center, Schillingallee 69a, 18057 Rostock, Germany. brigitte.vollmar@med.uni-rostock.de.
Sander BekeschusLeibniz-Institute for Plasma Science and Technology (INP Greifswald), Departments of Plasma Life Science and ZIK Plasmatis, Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany. sander.bekeschus@inp-greifswald.de.
Leibniz Institute for Plasma Science and Technology · DEUniversitätsmedizin Greifswald · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple evidence in animal models and in humans suggest a beneficial role of cold physical plasma in wound treatment. Yet, risk assessment studies are important to further foster therapeutic advancement and acceptance of cold plasma in clinics. Accordingly, we investigated the longterm side effects of repetitive plasma treatment over 14 consecutive days in a rodent full-thickness ear wound model. Subsequently, animals were housed for 350 days and sacrificed thereafter. In blood, systemic changes of the proinflammatory cytokines interleukin 1β and tumor necrosis factor α were absent. Similarly, tumor marker levels of α-fetoprotein and calcitonin remained unchanged. Using quantitative PCR, the expression levels of several cytokines and tumor markers in liver, lung, and skin were found to be similar in the control and treatment group as well. Likewise, histological and immunohistochemical analysis failed to detect abnormal morphological changes and the presence of tumor markers such as carcinoembryonic antigen, α-fetoprotein, or the neighbor of

Indexed as

AnimalsArgonBiomarkersBiopsyDisease Models, AnimalFemaleInflammationMaleMiceMultimodal ImagingPlasma GasesRisk AssessmentTime FactorsWound HealingWounds and InjuriesArgonBiomarkersPlasma Gasesdermal full-thickness woundskINPen plasma jetplasma medicinereactive oxygen and nitrogen speciesrisk evaluationSKH1 mouse model

Identifiers

PMID28422070
PMCPMC5412449
OpenAlexW2605691711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.